

Scientists at the University of Colorado Anschutz Medical Campus believe they have found the primary mechanism underlying cognitive decline associated with normal aging.
“The mechanism involves the misregulation of a brain protein known as CaMKII, which is crucial for memory and learning,” said the study’s co-senior author Ulli Bayer, Ph.D., professor of pharmacology at the University of Colorado School of Medicine. “This study directly suggests specific pharmacological treatment strategies.”
The findings were published in the journal Science Signaling today.
Using animal models, researchers discovered that changing the CaMKII brain protein generated cognitive consequences similar to those seen with natural aging.
According to Bayer, aging in mice and humans both decreases a process known as S-nitrosylation, which is the modification of certain brain proteins such as CaMKII.
The current study now shows a decrease in this modification of CaMKII is sufficient to cause impairments in synaptic plasticity and in memory that are similar in aging,” Bayer said.
Nitric oxide levels in the body decrease as we age. According to the study, this diminishes nitrosylation, which reduces memory and learning ability.
According to Bayer, the new discovery paves the path for the development of medications and other therapeutic approaches that could restore the protein’s nitrosylation. He claims that this opens the door of curing or delaying natural cognitive decline for an undetermined period of time.
He emphasized that this would only work in normal age-related cognitive decline, not in Alzheimer’s disease and dementia.
“We know this protein can be targeted,” Bayer said. “And we think it could be done pharmacologically. That is the next logical step.”
more recommended stories
Harmful Chemicals in Children’s Mattresses
A recent study has brought to.
TMS for Post-Stroke Aphasia Shows Remarkable Gains
A new clinical study led by.
CT Scan Overuse May Cause 1 in 20 New U.S. Cancers
A recent study published in JAMA.
Lactation Metabolism: Brain-Hormone Link Uncovered
Understanding how the body adjusts to.
Quantum Technology in Cancer Surgery: New Probe Aims to Improve Outcomes
A groundbreaking project from the University.
Bean-Based Gum Offers New Approach to Combat Influenza and Herpes
In an era where infectious diseases.
Shingles Vaccine May Cut Dementia Risk by 20%
A new study shows that the.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
Leave a Comment